期刊文献+

PCX、NGAL、VCAM-1联合检测对糖尿病肾病的诊断价值研究 被引量:5

The diagnostic value of PCX, NGAL and VCAM-1 in diabetic nephropathy
原文传递
导出
摘要 目的探讨尿液中足细胞标记蛋白(PCX)、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、血管内皮细胞黏附因子(VCAM-1)联合检测对糖尿病肾病的诊断价值。方法选取2018年8月至2019年8月本院收治的糖尿病肾病患者60例设为糖尿病肾病组,糖尿病非肾病患者60例设为糖尿病非肾病组.肾脏病患者60例设为肾脏病组.同时选取健康体检者60例设为对照组。检测四组受试者尿液中PCX、NCAL、VCAM-1的表达量。用受试者操作特征(ROC)曲线下面积分析尿液中PCX、NCAL、VCAM-1对糖尿病肾病的诊断价值。结果糖尿病肾病组患者尿液中PCX、NCAL、VCAM-1的表达量均高于糖尿病非肾病组和对照组(P<0.05)。糖尿病肾病组患者和糖尿病非肾病组的尿液中PCX、NCAL、VCAM-1单向检验的灵敏度分别为92%.92%.90%;特异度分别为74%.93%.74%。糖尿病肾病组和对照组的尿液中PCX、NGAL、VCAM-1单向检验的灵敏度分别为95%.95%.93%;特异度分别为92%.89%.90%。糖尿病肾病组和肾脏病组的尿液中PCX、NCAL、VCAM-1单向检验的灵敏度分别为98%.93%、88%;特异度分别为88%.87%.83%。尿液中PCX、NCAL、VCAM-1联合对糖尿病肾病的诊断灵敏度为93.33%,特异度为90.83%。结论尿液中PCX、NCAL、VCAM-1的表达量可作为联合诊断糖尿病肾病的潜在标志物。 Objective To explore the diagnostic value of combined detection of PCX,NGAL,and VCAM-1 in urine for diabetic nephropath.Methods From August 2018 to August 2019,60 dia-betic nephropathy patients were selected as diabetic nephropathy group,60 diabetic non-nephropathy patients as diabetic non-nephropathy group,60 renal patients as the kidney group,and 60 healthy physical examination patients as the control group.The expression levels of PCX,NCAL and VCAM-1 in urine of four groups were detected.The area under the ROC curve was used to analyze the diagnostic value of PCX,NGAL and VCAM-1 in urine.Results The expression levels of PCX,NGAL and VCAM-1 in urine of patients with diabetic nephropathy were higher than those of patients with diabetic non-nephropathy and healthy physical examination(P<0.05).The sensitivity of one-way tests of PCX,NGAL and VCAM-1 in urine of patients with diabetic nephropathy and non-diabetic nephropathy were 92%,92%and 90%,respectively;specificity was 74%,93%and 74%,respectively.The one-way tests of PCX,NGAL and VCAM-1 in urine of patients with diabetic nephropathy and control group were 95%,95%and 93%,and the specificities were 92%,89%and 90%,respectively.The sensitivity of one-way tests of PCX,NGAL and VCAM-1 in urine of patients in diabetic nephropathy group and kindnet group were 98%,93%and 88%,and specificity was 88%,87%and 83%,re-spectively.The sensitivity of urine PCX,NGAL,and VCAM-1 in the diagnosis of diabetic nephropathy was 93.33%and the specificity was 90.83%.Conclusions The expressions of PCX,NGAL and VCAM-1 in urine can be used as potential markers for the combined diagnosis of diabetic nephropathy.
作者 申宜梅 仲海峰 杨小华 韩晓骏 严冲 Shen Yimei;Zhong Haifeng;Yang Xiaohua;Han Xiaojun;Yan Chong(Department of Endocrinology,Hai'an Peoples Hospital,Hai'an 226600,China;Department of Nephrology,Haian People's Hospital,Haian 226600,China)
出处 《国际泌尿系统杂志》 2021年第3期498-502,共5页 International Journal of Urology and Nephrology
关键词 糖尿病肾病 尿 中性粒细胞明胶酶相关脂质运载蛋白 血管细胞粘附分子1 足糖萼蛋白 Diabetic Nephropathies Urine neutophil gelatinase-associated lipocalin Vascular Cell Adhesion Molecule-1 Podocalyxin
  • 相关文献

参考文献3

二级参考文献21

  • 1American Diabetes Association. Standards of medical care in diabetes--2014[J]. Diabetes Care, 2014, 37(Suppl 1): S14-S80.
  • 2Metzger BE, Lowe LP, Dyer AR, et al. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes[J]. N Engl J Med, 2008, 358: 1991-2002.
  • 3American Diabetes Association. Standards of medical care in diabetes--2011 [J]. Diabetes Care, 2011, 34(Suppl 1): S11-S61.
  • 4International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J]. Diabetes Care, 2010, 33: 676-682.
  • 5Ismail-Beigi F, Moghissi E, Tiktin M, et al. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials[J]. Ann Intern Med, 2011,154(8): 554-559.
  • 6Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus[J]. Diabetes Care, 2007, 30(Suppl 2): S251-S260.
  • 7Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report[J]. JAMA, 2003, 289(19): 2560-2572.
  • 8UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38[J]. BMJ, 1998, 317(7160): 703-713.
  • 9Hansson L, Zanchetti A, Carruthers SG, et al. HOT Study Group. Effects of intensive blood-pressure lowering and low- dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial[J]. Lancet, 1998, 351(9118): 1755-1762.
  • 10Adler AI, Stratton 1M, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study[J]. BMJ, 2000, 321(7258): 412-419.

共引文献50

同被引文献77

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部